2023

1. Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck

   Cancers, Vol. 15, Núm. 9

2. Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer

   Anti-Cancer Drugs, Vol. 34, Núm. 5, pp. 695-698

3. Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer

   Oncology Letters, Vol. 25, Núm. 1